Last updated: 2026-09-07 20:32:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
ENvue Medical, Inc. (FEED) operates in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector and is listed on NASDAQ. The stock is currently priced at $4.04, with a market capitalization of $3.72M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.48 to $73.08. This page covers its latest market performance, valuation, price trends and company information.
$3.72M | |
$4.00 | |
$2,557.19 | |
$3.48 | |
$3.83 | |
30.74K | |
96.16K | |
-- | |
$73.08 | |
$3.48 | |
-- | |
-- |
ENvue Medical, Inc. (FEED) last closed at $3.83 as of 2026-09-04 23:35:00, unchanged from the previous close of $3.83.
During the latest regular trading session, FEED traded between $3.48 and $2,557.19, with a volume of 30.74K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, ENvue Medical, Inc. (FEED) moved from $4.41 to $4.04, representing a decline of 8.49% ($0.37).
The stock traded between $3.77 and $4.76 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 39.72 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.8%
FEED is currently trading at $4.04, placing it 0.8% of the way from its 52-week low of $3.48 to its 52-week high of $73.08. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
ENvue Medical Inc is a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings. It focuses on two technology platforms: the ENvue Navigation Platform, which provides an electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract; FDA 510(k) cleared for adult use, it provides real-time bedside visualization of tube movement and supports informed decision-making during the placement procedure. Its Medical advances non-invasive therapy and minimally invasive navigation, with a commitment to patient safety, clinical usability, and technology innovation in healthcare environments, and the company's acoustic-based therapeutic technologies.
| Industry | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
| Employees | 14 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of ENvue Medical, Inc. (FEED) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.